Correlation Between Xenetic Biosciences and Fate Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Xenetic Biosciences and Fate Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Xenetic Biosciences and Fate Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Xenetic Biosciences and Fate Therapeutics, you can compare the effects of market volatilities on Xenetic Biosciences and Fate Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Xenetic Biosciences with a short position of Fate Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Xenetic Biosciences and Fate Therapeutics.

Diversification Opportunities for Xenetic Biosciences and Fate Therapeutics

-0.11
  Correlation Coefficient

Good diversification

The 3 months correlation between Xenetic and Fate is -0.11. Overlapping area represents the amount of risk that can be diversified away by holding Xenetic Biosciences and Fate Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fate Therapeutics and Xenetic Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Xenetic Biosciences are associated (or correlated) with Fate Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fate Therapeutics has no effect on the direction of Xenetic Biosciences i.e., Xenetic Biosciences and Fate Therapeutics go up and down completely randomly.

Pair Corralation between Xenetic Biosciences and Fate Therapeutics

Given the investment horizon of 90 days Xenetic Biosciences is expected to generate 0.65 times more return on investment than Fate Therapeutics. However, Xenetic Biosciences is 1.54 times less risky than Fate Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Fate Therapeutics is currently generating about -0.15 per unit of risk. If you would invest  432.00  in Xenetic Biosciences on September 29, 2024 and sell it today you would lose (21.00) from holding Xenetic Biosciences or give up 4.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Xenetic Biosciences  vs.  Fate Therapeutics

 Performance 
       Timeline  
Xenetic Biosciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Xenetic Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Xenetic Biosciences is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.
Fate Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Fate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Xenetic Biosciences and Fate Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Xenetic Biosciences and Fate Therapeutics

The main advantage of trading using opposite Xenetic Biosciences and Fate Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Xenetic Biosciences position performs unexpectedly, Fate Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fate Therapeutics will offset losses from the drop in Fate Therapeutics' long position.
The idea behind Xenetic Biosciences and Fate Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
CEOs Directory
Screen CEOs from public companies around the world